More than two-thirds – 67% - of first responders organisations have deployed new cybersecurity protections in the last 12 ...

The US FDA has expanded the approval of Regeneron Pharmaceuticals' fully human monoclonal antibody, Evkeeza (evinacumab-dgnb) ...

Amgen has revealed a significant investment plan, earmarking $650m to enhance its manufacturing operations in the US.

Evaxion’s preclinical asset targets an unknown infectious disease in which there are no other vaccines available.

The 100% rate on imported, branded pharma products will not apply to drugmakers constructing manufacturing facilities in the ...

Lilly has received approval from the US Food and Drug Administration (FDA) for Inluriyo (imlunestrant) to treat advanced ...

After demonstrating that its gene therapy can slash Huntington's disease progression by 75%, Uniqure will now file for ...

Bucking the trend of IL-12 therapy programme failures, Imunon’s IMNN-001 was bolstered by positive translational data in ...

Sanofi has committed an additional $625m to its venture capital arm, Sanofi Ventures, bringing its total assets under ...

Patients will now be able to access BMS' Sotyktu for significantly cheaper than current list prices, alongside BMS and Pfizer ...

Lithuania is rapidly growing as a leading force in the European life sciences scene, with over 400 life sciences companies in ...